A diagnostic panel assay for the detection of human papillomavirus using ERA technology. The assay provides rapid and accurate identification of HPV infections.
Manufactured by
Suzhou, Jiangsu, China
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems. Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE ® systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
APPOLON BIOTECK SAS
France · 1 relevant product
shanghai rendu biotechnology co.,ltd.
China · 2 relevant products
Yaneng BIOscience (Shenzhen) Co.,Ltd.
China · 8 relevant products
Suzhou Molarray Co., Ltd.
China · 1 relevant product
SeeGene Middle East FZE
South Korea · 3 relevant products
Credo Diagnostics Biomedical Pte. Ltd.
Singapore · 1 relevant product
Attogen Biomedical(Suzhou)Ltd.Inc
China · 6 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 5 relevant products
Advanced Molecular Diagnostics Ltd.
United Kingdom · 4 relevant products
42 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
APPOLON BIOTECK SAS · France
A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
shanghai rendu biotechnology co.,ltd. · China
AmpSure® HPV Assay is an in vitro diagnostic test for the detection and identification of human papillomavirus RNA in clinical specimens. The assay leverages advanced RNA detection technology to deliver precise results for cervical cancer screening and HPV-related disease management. Designed for clinical laboratory use with optimized sensitivity and specificity.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
HPV genotyping assay detecting 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82 high-risk variants for comprehensive cervical cancer risk assessment.
Suzhou Molarray Co., Ltd. · China
A molecular assay for the detection of specific genetic sequences or mutations in patient samples. The test is used in genetic screening, disease diagnosis, and personalized medicine applications.
shanghai rendu biotechnology co.,ltd. · China
The AmpSure® HPV 16/18 Genotype Assay is an in vitro diagnostic test for detecting and genotyping human papillomavirus (HPV) types 16 and 18 in clinical specimens. This molecular assay enables precise identification of high-risk HPV strains associated with cervical cancer and related malignancies, supporting clinical screening and risk stratification protocols.
SeeGene Middle East FZE · South Korea
The Allplex HPV28 Assay is a real-time PCR-based diagnostic test that simultaneously detects 28 human papillomavirus (HPV) types for cervical cancer screening and risk stratification. This high-multiplex assay integrates seamlessly into automated laboratory workflows, enabling rapid syndromic detection with comprehensive HPV genotyping in a single reaction.
Credo Diagnostics Biomedical Pte. Ltd. · Singapore
A point-of-care testing assay that detects and differentiates high-risk HPV subtypes. Enables rapid screening for cervical cancer risk at the point of care.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
HLB PANAGENE Co., Ltd. · South Korea
A comprehensive HPV genotyping assay for detection and identification of human papillomavirus types in cervical and other samples.
Yaneng BIOscience (Shenzhen) Co.,Ltd. · China
PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.
Advanced Molecular Diagnostics Ltd. · United Kingdom
Real-time PCR assay for high-risk HPV detection and screening. Supports cervical cancer prevention through HPV risk assessment.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products